The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Feasibility study of diet counseling (DC) with oral nutritional supplements (ONS) for advanced esophageal and gastric cancer during chemotherapy (CT) or chemoradiotherapy (CRT): First report of ONS compliance from a prospective randomized controlled clinical study (DiCON study).
 
Yukiko Izawa
No Relationships to Disclose
 
Takashi Ichimura
Speakers' Bureau - Lilly Japan; Ono Pharmaceutical
Research Funding - Clinico
 
Keisho Chin
No Relationships to Disclose
 
Eiji Shinozaki
Honoraria - Chugai Pharma; Lilly; Merck Serono; Novartis; Sanofi; Taiho Pharmaceutical; Takeda; Yakult Honsha
 
Daisuke Takahari
Honoraria - Bristol-Myers Squibb Japan; Chugai Pharma; Lilly Japan; Ono Pharmaceutical; Taiho Pharmaceutical; Yakult Honsha
Research Funding - Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)
 
Mitsukuni Suenaga
Honoraria - Chugai/Roche; Merck Serono
 
Mariko Ogura
No Relationships to Disclose
 
Takeru Wakatsuki
No Relationships to Disclose
 
Hiroki Osumi
No Relationships to Disclose
 
Izuma Nakayama
No Relationships to Disclose
 
Shinji Mine
No Relationships to Disclose
 
Naoki Hiki
Consulting or Advisory Role - Medtronic
 
Naoki Ishizuka
Stock and Other Ownership Interests - Sanofi
Research Funding - Taiho Pharmaceutical (Inst)
 
Kensei Yamaguchi
Consulting or Advisory Role - Bristol-Myers Squibb Japan; Daiichi Sankyo
Speakers' Bureau - Bristol-Myers Squibb Japan; Chugai Pharma; Lilly; Merck Serono; Ono Pharmaceutical; Sanofi; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - Daiichi Sankyo (Inst); Dainippon Sumitomo Pharma (Inst); Gilead Sciences (Inst); Lilly (Inst); MSD Oncology (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Yakult Honsha (Inst)